Results overview: Found 5 records in 0.02 seconds.
Articles, 5 records found
Articles 5 records found  
1.
33 p, 1.7 MB Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials / Ibanez, Borja (Cardiology Department, IIS Fundación Jiménez Díaz Hospital, Madrid, Spain) ; Aletras, Anthony H. (Lund University, Department of Clinical Sciences Lund, Clinical Physiology, Skane University Hospital, Lund, Sweden) ; Arai, Andrew E. (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland) ; Arheden, Hakan (Lund University, Department of Clinical Sciences Lund, Clinical Physiology, Skane University Hospital, Lund, Sweden) ; Bax, Jeroen (Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, the Netherlands) ; Berry, Colin (British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, and Golden Jubilee National Hospital, Clydebank, United Kingdom) ; Bucciarelli-Ducci, Chiara (Bristol Heart Institute, Bristol NIHR Cardiovascular Research Centre, University of Bristol and University Hospitals Bristol NHS Trust, Bristol, United Kingdom) ; Croisille, Pierre (University Lyon, UJM-Saint-Etienne, INSA, CNRS UMR 5520, INSERM U1206, CREATIS, F-42023, Saint-Etienne, France) ; Dall'Armellina, Erica (Leeds Institute of Cardiovascular and Metabolic Medicine, Department of Biomedical Imaging Sciences, University of Leeds, Leeds, United Kingdom) ; Dharmakumar, Rohan (Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, and Division of Cardiology, Department of Medicine, University of California, Los Angeles, California) ; Eitel, Ingo (University Heart Center Lübeck, Medical Clinic II (Cardiology/ Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Lübeck, Germany) ; Fernández-Jiménez, Rodrigo (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ; Friedrich, Matthias G. (Department of Medicine, Heidelberg University, Heidelberg, Germany) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca ) ; Hausenloy, Derek J. (Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA, Nuevo Leon, Mexico) ; Kim, Raymond J. (Duke Cardiovascular Magnetic Resonance Center, Division of Cardiology, and Department of Radiology, Duke University Medical Center, Durham, North Carolina) ; Kozerke, Sebastian (Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland) ; Kramer, Christopher M. (Departments of Medicine and Radiology, University of Virginia Health System, Charlottesville, Virginia) ; Salerno, Michael (Departments of Medicine and Radiology, University of Virginia Health System, Charlottesville, Virginia; and) ; Sánchez-González, Javier (Philips Healthcare, Madrid, Spain) ; Sanz, Javier (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ; Fuster, Valentin (Cardiology Department, Icahn School of Medicine at Mount Sinai, New York, New York) ; Universitat Autònoma de Barcelona
After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema, inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and ultimately replacement by fibrosis). [...]
2019 - 10.1016/j.jacc.2019.05.024
Journal of the American College of Cardiology, Vol. 74 (july 2019) , p. 238-256  
2.
6 p, 488.0 KB Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients / Bulluck, Heerajnarain (National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore) ; Nicholas, Jennifer (London School Hygiene and Tropical Medicine, London, UK) ; Crimi, Gabriele (Struttura Complessa Cardiologia, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy) ; White, Steven K (The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, UK) ; Ludman, Andrew J (Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK) ; Pica, Silvia (Struttura Complessa Cardiologia, Azienda Ospedaliera SS: Antonio e Biagio, Alessandria, Italy) ; Raineri, Claudia (Struttura Complessa Cardiologia, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia) ; Cabrera-Fuentes, Hector A (Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore) ; Yellon, Derek (The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London) ; Rodriguez-Palomares, Jose (Hospital Universitari Vall d'Hebron) ; Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ; Hausenloy, Derek J (Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore) ; Universitat Autònoma de Barcelona
Clinical studies using serum cardiac biomarkers to investigate a circadian variation in acute myocardial infarct (MI) size in ST-segment elevation myocardial infarction (STEMI) patients reperfused by primary percutaneous coronary intervention (PPCI) have produced mixed results. [...]
2017 - 10.1016/j.ijcard.2016.12.030
International Journal of Cardiology, Vol. 230 (march 2017) , p. 149-154  
3.
11 p, 337.7 KB Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction : trials and tribulations / Hausenloy, Derek J. (National Institute of Health Research University College London Hospitals Biomedical Research Centre, London W1T 7DN, UK) ; Botker, Hans Erik (Department of Cardiology, Aarhus University Hospital Skejby, DK-8200 Aarhus N, Denmark) ; Engstrom, Thomas (Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark) ; Erlinge, David (Department of Cardiology, Lund University, Lund, Sweden) ; Heusch, Gerd (Institute for Pathophysiology, West German Heart and Vascular Center, University of Essen Medical School, Essen, Germany) ; Ibanez, Borja (IIS-Fundación Jiménez Díaz Hospital, Madrid, Spain) ; Kloner, Robert A. (Division of Cardiovascular Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA) ; Ovize, Michel (UMR 1060 (CarMeN), Université Claude Bernard, Lyon, France) ; Yellon, Derek M. (National Institute of Health Research University College London Hospitals Biomedical Research Centre, London W1T 7DN, UK) ; Garcia-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
2016 - 10.1093/eurheartj/ehw145
European heart journal, Vol. 38 (april 2016) , p. 935-941  
4.
10 p, 1.1 MB Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients : An updated meta-analysis of randomized controlled trials / Bulluck, Heerajnarain (The Heart Hospital) ; Sirker, Alex (The Heart Hospital) ; Loke, Yoon K. (University of East Anglia) ; Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ; Hausenloy, Derek J. (National Heart Research Institute Singapore) ; Universitat Autònoma de Barcelona
Adenosine administered as an adjunct to reperfusion can reduce coronary no-reflow and limit myocardial infarct (MI) size in ST-segment elevation myocardial infarction (STEMI) patients. Whether adjunctive adenosine therapy can improve clinical outcomes in reperfused STEMI patients is not clear and is investigated in this meta-analysis of 13 randomized controlled trials (RCTs). [...]
2016 - 10.1016/j.ijcard.2015.09.005
International Journal of Cardiology, Vol. 202 (january 2016) , p. 228-237  
5.
13 p, 340.4 KB ESC working group cellular biology of the heart : position paper: improving the preclinical assessment of novel cardioprotective therapies / Lecour, Sandrine (Hatter Institute for Cardiovascular Research (Àfrica)) ; Bøtker, Hans E. (Aarhus Universitetshospital) ; Condorelli, Gianluigi (Instituto Clinico Humanitas (Milano, Itàlia)) ; Davidson, Sean M. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit)) ; García Dorado, David (Universitat Autònoma de Barcelona) ; Engel, Felix B. (Friedrich-Alexander-Universität Erlangen-Nürnberg) ; Ferdinandy, Peter (Semmelweis Egyetem. Department of Pharmacology and Pharmacotherapy) ; Heusch, Gerd (Universitätsklinikum Essen) ; Madonna, Rosalinda (Università degli Studi "G. d'Annunzio" Chieti) ; Ovize, Michel (Université Claude Bernard Lyon 1) ; Ruiz-Meana, Marisol (Hospital Universitari Vall d'Hebron) ; Schulz, Rainer (Justus Liebig-Universität Gießen) ; Sluijter, Joost P.G. (Universitair Medisch Centrum Utrecht) ; Van Laake, Linda W. (Universitair Medisch Centrum Utrecht) ; Yellon, Derek M. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit)) ; Hausenloy, Derek J. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit))
Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemia-reperfusion injury, in order to improve clinical outcomes in IHD patients. [...]
2014 - 10.1093/cvr/cvu225
Cardiovascular research, Vol. 104, issue 3 (Dec. 2014) , p. 399-411  

See also: similar author names
4 Hausenloy, D.J.
1 Hausenloy, Derek J
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.